{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-26-004648","form_type":"8-K","ticker":"PGEN","cik":"0001356090","company_name":"PRECIGEN, INC.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.907441+00:00","generated_at":"2026-05-15T08:58:51.255253+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Precigen posts FY2025 net loss of $1.37/sh; PAPZIMEOS Q4 revenue $3.4M, launch momentum strong","bullets":["PAPZIMEOS generated $3.4M in net product revenue in Q4 2025, first partial quarter of US commercial sales.","Cash, cash equivalents, and investments $100.4M as of Dec 31, 2025, expected to fund to cash flow break-even.","Patient hub enrollment >300; payer coverage ~215M lives (~90% insured US); CMS assigned permanent J-code effective Apr 1, 2026.","Net loss attributable to common shareholders $429.6M ($1.37/sh) vs $126.2M ($0.47) in 2024, driven by non-cash warrant and preferred stock items.","R&D expenses down 22.1% YoY; SG&A up 69.8% reflecting commercial launch investment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-26-004648","json":"https://secwatch.observer/filing/0000950103-26-004648.json","markdown":"https://secwatch.observer/filing/0000950103-26-004648.md","text":"https://secwatch.observer/filing/0000950103-26-004648.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326004648/0000950103-26-004648-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326004648/dp244075_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:58:51.255253+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}